selected publications
-
Seroprevalence of SARS-CoV-2 antibodies in dogs and cats during the early and mid-pandemic periods in Japan.
One health (Amsterdam, Netherlands).
2023
Academic Article
GET IT
Times cited: 3 - Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct Omicron subvariants. The Journal of clinical investigation. 2023 Academic Article GET IT
- Ferret model to mimic the sequential exposure of humans to historical H3N2 influenza viruses. Vaccine. 2022 Academic Article GET IT
- A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases. Nature communications. 2022 Academic Article GET IT
- Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022. Emerging infectious diseases. 2022 Academic Article GET IT
- Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters. Nature microbiology. 2022 Academic Article GET IT
- Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2. Nature. 2022 Academic Article GET IT
- Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan. Internal medicine (Tokyo, Japan). 2022 Academic Article GET IT
- Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization. Microbiology spectrum. 2022 Academic Article GET IT
-
ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury.
Nature communications.
2021
Academic Article
GET IT
Times cited: 37 -
Characterization of a new SARS-CoV-2 variant that emerged in Brazil.
Proceedings of the National Academy of Sciences of the United States of America.
2021
Academic Article
GET IT
Times cited: 54 -
Longitudinal antibody repertoire in "mild" versus "severe" COVID-19 patients reveals immune markers associated with disease severity and resolution.
Science advances.
2021
Academic Article
GET IT
Times cited: 56 -
Antibody titers against SARS-CoV-2 decline, but do not disappear for several months.
EClinicalMedicine.
2021
Academic Article
GET IT
Times cited: 112 -
Comparison of Rapid Antigen Tests for COVID-19.
Viruses.
2020
Academic Article
GET IT
Times cited: 164 -
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
Proceedings of the National Academy of Sciences of the United States of America.
2020
Academic Article
GET IT
Times cited: 707 - Comparison of the Pathogenicity in Mice of A(H1N1)pdm09 Viruses Isolated between 2009 and 2015 in Japan. Viruses. 2020 Academic Article GET IT
-
Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets.
Nature microbiology.
2019
Academic Article
GET IT
Times cited: 45 -
Soluble Recombinant Hemagglutinin Protein of H1N1pdm09 Influenza Virus Elicits Cross-Protection Against a Lethal H5N1 Challenge in Mice.
Frontiers in microbiology.
2019
Academic Article
GET IT
Times cited: 9 -
Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus.
Nature microbiology.
2019
Academic Article
GET IT
Times cited: 14 -
Genetic and antigenic characterisation of influenza A(H3N2) viruses isolated in Yokohama during the 2016/17 and 2017/18 influenza seasons.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
2019
Academic Article
GET IT
Times cited: 18 -
Isolation and Characterization of Human Monoclonal Antibodies That Recognize the Influenza A(H1N1)pdm09 Virus Hemagglutinin Receptor-Binding Site and Rarely Yield Escape Mutant Viruses.
Frontiers in microbiology.
2018
Academic Article
GET IT
Times cited: 10 -
Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
2018
Academic Article
GET IT
Times cited: 13 -
Evaluation of the fusion partner cell line SPYMEG for obtaining human monoclonal antibodies against influenza B virus.
The Journal of veterinary medical science.
2018
Academic Article
GET IT
Times cited: 2 -
Enhanced Replication of Highly Pathogenic Influenza A(H7N9) Virus in Humans.
Emerging infectious diseases.
2018
Academic Article
GET IT
Times cited: 32 -
Diversity of antigenic mutants of influenza A(H1N1)pdm09 virus escaped from human monoclonal antibodies.
Scientific reports.
2017
Academic Article
GET IT
Times cited: 21 -
A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets.
Cell host & microbe.
2017
Academic Article
GET IT
Times cited: 117 -
A Broadly Reactive Human Anti-hemagglutinin Stem Monoclonal Antibody That Inhibits Influenza A Virus Particle Release.
EBioMedicine.
2017
Academic Article
GET IT
Times cited: 49 -
Risk assessment of recent Egyptian H5N1 influenza viruses.
Scientific reports.
2016
Academic Article
GET IT
Times cited: 17